Daniel Seekins

1.2k total citations
30 papers, 746 citations indexed

About

Daniel Seekins is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Daniel Seekins has authored 30 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Emergency Medicine. Recurrent topics in Daniel Seekins's work include HIV/AIDS Research and Interventions (20 papers), HIV/AIDS drug development and treatment (16 papers) and HIV-related health complications and treatments (8 papers). Daniel Seekins is often cited by papers focused on HIV/AIDS Research and Interventions (20 papers), HIV/AIDS drug development and treatment (16 papers) and HIV-related health complications and treatments (8 papers). Daniel Seekins collaborates with scholars based in United States, Germany and United Kingdom. Daniel Seekins's co-authors include Jen‐Fue Maa, Timothy Juday, Dana P. Goldman, Michael J. Kozal, Birgitte B. Simen, Jonathan Uy, Max Lataillade, Rong Yang, Edwin DeJesus and Jennifer Chiarella and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and The Journal of Infectious Diseases.

In The Last Decade

Daniel Seekins

30 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Seekins United States 19 532 324 211 161 63 30 746
Julie A. Predhomme United States 13 581 1.1× 272 0.8× 227 1.1× 114 0.7× 73 1.2× 17 749
Helen Reynolds United Kingdom 15 397 0.7× 184 0.6× 134 0.6× 117 0.7× 56 0.9× 40 661
Michael Lamson United States 12 579 1.1× 398 1.2× 132 0.6× 114 0.7× 101 1.6× 25 842
C. J. L. la Porte Canada 11 433 0.8× 201 0.6× 137 0.6× 91 0.6× 62 1.0× 16 546
Antonio Antela Spain 18 678 1.3× 362 1.1× 391 1.9× 330 2.0× 16 0.3× 49 947
Megan Turner United States 14 637 1.2× 306 0.9× 199 0.9× 525 3.3× 11 0.2× 39 910
Patrick G. Clay United States 15 346 0.7× 134 0.4× 183 0.9× 118 0.7× 20 0.3× 41 791
Simona Landonio Italy 17 615 1.2× 335 1.0× 203 1.0× 256 1.6× 26 0.4× 32 776
Marcel Stoeckle Switzerland 14 336 0.6× 152 0.5× 169 0.8× 101 0.6× 27 0.4× 54 517
Asgeir Johannessen Norway 16 455 0.9× 299 0.9× 418 2.0× 148 0.9× 10 0.2× 55 902

Countries citing papers authored by Daniel Seekins

Since Specialization
Citations

This map shows the geographic impact of Daniel Seekins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Seekins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Seekins more than expected).

Fields of papers citing papers by Daniel Seekins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Seekins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Seekins. The network helps show where Daniel Seekins may publish in the future.

Co-authorship network of co-authors of Daniel Seekins

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Seekins. A scholar is included among the top collaborators of Daniel Seekins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Seekins. Daniel Seekins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Albano, Jessica D., Angela E. Scheuerle, D. Heather Watts, et al.. (2024). The Antiretroviral Pregnancy Registry: Three decades of prospective monitoring for birth defects. Pharmacoepidemiology and Drug Safety. 33(6). e5801–e5801. 2 indexed citations
3.
Hey‐Hadavi, J., Daniel Seekins, Melissa Palmer, et al.. (2021). Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials. Drug Safety. 44(6). 619–634. 20 indexed citations
5.
Nkhoma, Ella T., Amanda M. Farr, Stephen S. Johnston, et al.. (2016). No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data. Medicine. 95(3). e2480–e2480. 18 indexed citations
6.
Pavía-Ruz, Noris, Xavier Sáez‐Llorens, Torsak Bunupuradah, et al.. (2015). Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age. The Pediatric Infectious Disease Journal. 34(12). 1355–1360. 4 indexed citations
7.
Reveles, Kelly R., Matthew J. Labreche, Eric M. Mortensen, et al.. (2015). Comparative Value of Four Measures of Retention in Expert Care in Predicting Clinical Outcomes and Health Care Utilization in HIV Patients. PLoS ONE. 10(3). e0120953–e0120953. 13 indexed citations
8.
Napoli, Andrew, et al.. (2014). No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database. Journal of the International AIDS Society. 17(1). 19214–19214. 29 indexed citations
9.
Snider, Julia Thornton, Timothy Juday, John A. Romley, et al.. (2014). Nearly 60,000 Uninsured And Low-Income People With HIV/AIDS Live In States That Are Not Expanding Medicaid. Health Affairs. 33(3). 386–393. 35 indexed citations
10.
Goldman, Dana P., Timothy Juday, Daniel Seekins, Mark T. Linthicum, & John A. Romley. (2014). Early HIV Treatment In The United States Prevented Nearly 13,500 Infections Per Year During 1996–2009. Health Affairs. 33(3). 362–369. 18 indexed citations
11.
Goldman, Dana P., Timothy Juday, Mark T. Linthicum, Lisa Rosenblatt, & Daniel Seekins. (2014). The Prospect Of A Generation Free Of HIV May Be Within Reach If The Right Policy Decisions Are Made. Health Affairs. 33(3). 428–433. 9 indexed citations
12.
Schneider, G, Timothy Juday, Charles Wentworth, et al.. (2013). Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA. AIDS Care. 25(11). 1470–1476. 10 indexed citations
13.
Johnston, Stephen S., Timothy Juday, Daniel Seekins, Derek Espindle, & Bong-Chul Chu. (2012). Association Between Prescription Cost Sharing and Adherence to Initial Combination Antiretroviral Therapy in Commercially Insured Antiretroviral-Naïve Patients with HIV. Journal of Managed Care Pharmacy. 18(2). 129–145. 17 indexed citations
14.
Lataillade, Max, Jennifer Chiarella, Rong Yang, et al.. (2012). Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing. PLoS ONE. 7(2). e30118–e30118. 31 indexed citations
16.
DeJesus, Edwin, Benjamin Young, Javier O Morales-Ramirez, et al.. (2009). Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(2). 163–174. 108 indexed citations
18.
Flandre, Philippe, Colombe Chappey, Anne‐Geneviève Marcelin, et al.. (2007). Phenotypic Susceptibility to Didanosine Is Associated with Antiviral Activity in Treatment‐Experienced Patients with HIV‐1 Infection. The Journal of Infectious Diseases. 195(3). 392–398. 10 indexed citations
19.
Haas, David W., W. Jeffrey Fessel, Robert Delapenha, et al.. (2001). Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse‐Transcriptase Inhibitor Experience: A Randomized, Double‐Blind, Placebo‐Controlled Trial. The Journal of Infectious Diseases. 183(3). 392–400. 27 indexed citations
20.
Dobs, Adrian S., Joseph Cofrancesco, Ann Danoff, et al.. (1999). The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection. The American Journal of Medicine. 107(2). 126–132. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026